199 related articles for article (PubMed ID: 10831636)
1. Steroid and cyclophosphamide in IgA nephropathy.
Roccatello D; Ferro M; Cesano G; Rossi D; Berutti S; Salomone M; Piccoli G; Sena LM
Nephrol Dial Transplant; 2000 Jun; 15(6):833-5. PubMed ID: 10831636
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression.
Roccatello D; Rossi D; Marletto F; Naretto C; Sciascia S; Baldovino S; Piras D; Giachino O
J Nephrol; 2012; 25(2):198-203. PubMed ID: 21725921
[TBL] [Abstract][Full Text] [Related]
3. Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
Tumlin JA; Lohavichan V; Hennigar R
Nephrol Dial Transplant; 2003 Jul; 18(7):1321-9. PubMed ID: 12808169
[TBL] [Abstract][Full Text] [Related]
4. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
Pozzi C; Andrulli S; Pani A; Scaini P; Roccatello D; Fogazzi G; Pecchini P; Rustichelli R; Finocchiaro P; Del Vecchio L; Locatelli F
J Nephrol; 2013; 26(1):86-93. PubMed ID: 22460183
[TBL] [Abstract][Full Text] [Related]
5. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
6. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
7. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy.
Tumlin JA; Hennigar RA
Semin Nephrol; 2004 May; 24(3):256-68. PubMed ID: 15156530
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W
Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
[TBL] [Abstract][Full Text] [Related]
10. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
[TBL] [Abstract][Full Text] [Related]
11. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
Pozzi C; Del Vecchio L; Locatelli F
G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic IgA nephropathy with segmental necrotizing lesions of the capillary wall.
D'Amico G; Napodano P; Ferrario F; Rastaldi MP; Arrigo G
Kidney Int; 2001 Feb; 59(2):682-92. PubMed ID: 11168950
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
15. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
Manno C; Torres DD; Rossini M; Pesce F; Schena FP
Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
[TBL] [Abstract][Full Text] [Related]
17. [Multicenter investigation of therapeutic status of children with IgA nephropathy in China].
Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):486-90. PubMed ID: 24267127
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
du Buf-Vereijken PW; Branten AJ; Wetzels JF;
Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
[TBL] [Abstract][Full Text] [Related]
20. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
García Camín RM; Cabezas A; Calero F; Ballarín JA
Nefrologia; 2004; 24 Suppl 3():68-71. PubMed ID: 15219073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
